Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human Serv”

1,157 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,157
Index total 30,257
Page 14 / 49

Quick answer

This filtered view shows 1,157 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,157 results for “The United States of America, as represented by the Secretary, Department of Health and Human Serv” · 30,257 patents in full index Clear search

  1. US 11013803

    Near infrared photoimmunotherapy (NIR-PIT) of suppressor cells to treat cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 25, 2021 · Expires May 20, 2041

    granted

  2. US 11007249

    Compositions comprising pregnancy specific glycoproteins and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 18, 2021 · Expires May 13, 2041

    granted

  3. US 10988472

    Compounds and method for blocking transmission of malarial parasite

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted

  4. US 10988778

    Codon-optimized reduced-size ATP7A cDNA and uses for treatment of copper transport disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted

  5. US 10980872

    Genetically stable live attenuated respiratory syncytial virus vaccine and its production

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  6. US 10980846

    Use of gram negative species to treat atopic dermatitis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  7. US 10981866

    Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  8. US 10961283

    Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  9. US 10961200

    Small molecule inhibitors of lactate dehydrogenase and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  10. US 10960070

    Prefusion coronavirus spike proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  11. US 10953026

    N-acetyl mannosammine as a therapeutic agent

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  12. US 10954291

    Monoclonal antibodies that specifically bind to matrilin-3 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  13. US 10954492

    Processes for production and purification of nucleic acid-containing compositions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  14. US 10953083

    Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  15. US 10947277

    Nucleic acids encoding zika virus-like particles and their use in zika virus vaccines and diagnostic assays

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted

  16. US 10946048

    Use of gram negative species to treat atopic dermatitis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted

  17. US 10946049

    Use of gram negative species to treat atopic dermatitis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted

  18. US 10941187

    GLP-1, exendin-4, peptide analogs and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted

  19. US 10940241

    Formation of stable cartilage

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted

  20. US 10940188

    Compounds and methods for treatment and prevention of Flavivirus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted

  21. US 10925874

    Substituted pyrazolopyrimidines as glucocerebrosidase activators

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted

  22. US 10925969

    Anti-BCMA polypeptides and proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted

  23. US 10913785

    Anti-human papillomavirus 16 E6 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted

  24. US 10913709

    STAT3 inhibitor formulation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.